We further investigated the CD4+/CD8+ ratio in mouse and human samples and found that mrHCC2 samples, whether from mouse models or the human HCC cohort, have significantly higher ratios than mrHCC1 and mrHCC3 (p < 0.05) (Fig. 5c). This evidence concerns the gene CD4 and hepatocellular carcinoma.